Ishak stage 6 fibrosis is more likely to regress than stage 5 in CHB patients undergoing entecavir therapy
接受恩替卡韦治疗的慢性乙型肝炎患者中,Ishak 6期纤维化比5期纤维化更容易消退。
期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2026.1765594
Li, Mengjie; Hao, Xiaogang; Li, Yuanyuan; Zhang, Chao; Chen, Yongping; Yu, Zujiang; Li, Qin; Tan, Lin; Xiang, Dedong; Shang, Qinghua; Lei, Chunliang; Chen, Liang; Hu, Xiaoyu; Wang, Jing; Liu, Huabao; Lu, Wei; Chen, Yan; Dong, Zheng; Bai, Wenlin; Yoshida, Eric M; Mendez-Sanchez, Nahum; Hu, Ke-Qin; Qi, Xingshun; Yang, Yongping; Bi, Jingfeng